Marta del Pino | Medicine | Best Researcher Award

Published on by Scientific World Research Awards

Best Researcher Award

Marta del Pino — Hospital Clínic de Barcelona, Spain

Marta del Pino 
Affiliation Hospital Clínic de Barcelona
Country Spain
Scopus ID 8428840400
Documents 109
Citations 3,648
h-index 35
Subject area Medicine
Event Scientific World Research Awards
ORCID 0000-0003-2178-2403

Marta del Pino is a researcher whose research contributions include publications in clinical medicine, gynaecological disease, and related areas of diagnostic research. Her ORCID record lists research works and providing a persistent identifier through which readers can explore publications and contributor information.  [1]

1. Abstract

This article presents a research profile of Marta del Pino in the field of medicine, based on the research metrics. Her documented publications address HPV-related disease, cervical screening, gynaecological pathology, vaccination and clinical outcomes. These topics contribute to ongoing research on disease prevention, diagnosis and patient care. [2]

2. Keywords

Marta del Pino; Medicine; human papillomavirus; cervical cancer screening; gynaecological oncology; clinical research; HPV vaccination; diagnostic methods; research publications; scholarly impact; Scientific World Research Awards.

3. Introduction

Medical research connects laboratory findings, population-level evidence and clinical practice. Research on HPV and gynaecological disease is particularly relevant to screening strategies, prevention and the assessment of disease progression. The works listed in del Pino’s ORCID record document participation in this multidisciplinary research landscape.[1]

4. Research Profile

The Research profile identifies Hospital Clínic de Barcelona in Spain as the researcher’s affiliation and medicine as the subject area. It reports 109 documents, 3,648 citations and an h-index of 35; these figures are supplied metrics and should be checked against the current Scopus profile before formal publication.[2]

5. Research Contributions

The ORCID record includes collaborative publications concerning HPV-associated cervical lesions, vaccination, cervical cancer screening and gynaecological pathology. Examples include research on HPV vaccination in women undergoing excisional treatment and studies examining the classification and prognosis of HPV-associated tumours.  [1]

6. Publications

Selected works listed in the record include “HPV Vaccination in Women with Cervical Intraepithelial Neoplasia Undergoing Excisional Treatment: Insights into Unsolved Questions” and “Risk factors for human papillomavirus infection and disease: A targeted literature summary.” The record also lists collaborative studies on cervical screening and the molecular features of gynaecological cancers [3]

7. Research Impact

The bibliometric figures—109 documents, 3,648 citations, and an h-index of 35—offer one quantitative snapshot of scholarly output and citation activity.  Marta del Pino’s research advances understanding of human papillomavirus (HPV) infection and vaccination outcomes. Her scientific contributions support improved cervical screening strategies and evidence-based approaches to women’s health.. [2]

8. Award Suitability

The Best Researcher Award profile recognises a documented record of scholarly contributions in medicine. The research metrics and publications can support an initial review of research activity. Final award decisions should follow the Scientific World Research Awards’ evaluation criteria and independent verification of the researcher’s identity, outputs and citation data

9. Conclusion

Marta del Pino’s ORCID-listed works document collaborative research across HPV-related disease and gynaecological medicine. Her profile provides a starting point for reviewing publication activity and subject-area contributions. Maintaining accurate identifiers, verified bibliographic records and transparent evaluation methods is important for responsible academic recognition. [1]

11. References

  1. ORCID. (2026). Marta del Pino — ORCID record
    https://orcid.org/0000-0003-2178-2403
  2. Elsevier. (n.d.). Scopus author details: Marta del Pino, Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=8428840400
  3. de la Fuente-Valero, J., Rejas-Gutiérrez, J., del Pino, M., et al. (2026). Health Outcome Determinants of Human Papillomavirus Vaccination in Adult Women in Spain. Vaccines.
    https://doi.org/10.3390/vaccines14050460
  4. Díez-Ahijado, L., Marcén del Rincón, A., Marimón, L., et al. (2025). HTGAnalyzer: An accessible R package with a web interface for enhanced transcriptomic analysis in precision medicine. Computers in Biology and Medicine.
    https://doi.org/10.1016/j.compbiomed.2025.110772
  5. International Journal of Gynecology & Obstetrics. (2026). FIGO/IGCS statement on the efficacy of topical treatments for high-risk human papillomavirus in preventing CIN 3+ lesions.
    https://doi.org/10.1002/ijgo.71285

Rossella Cacciola | Medicine | Innovative Research Award

Published on by Scientific World Research Awards

Innovative Research Award

Rossella Cacciola — University of Catania, Italy

Rossella Cacciola
Affiliation University of Catania
Country Italy
Scopus ID 7003944169
Documents 99
Citations 2,808
h-index 27
Subject Area Medicine
Event Scientific World Research Awards
ORCID 0000-0003-1440-2695

Rossella Cacciola is a medical researcher and her documented scholarly work covers hematology, molecular diagnostics, plasma-cell disorders, and thrombosis. Her research record provides information about her publications and research activities, offering a foundation for understanding her scientific interests. [1]

Abstract

This article presents an academic profile of Rossella Cacciola and highlights selected research topics documented in her scholarly record. Her publications address hematological conditions, molecular testing methods, and disease-related mechanisms. These subjects contribute to continuing scientific investigation and the development of medical knowledge. [1]

Keywords

Hematology, molecular diagnostics, plasma-cell disorders, multiple myeloma, thrombosis, polycythemia vera, clinical research, medical science, and laboratory investigation.

Introduction

Medical research advances understanding of disease through clinical observation, laboratory analysis, and scientific collaboration. Cacciola’s documented publications provide examples of research into hematological disorders and diagnostic approaches. Her research profile can be explored through recognized researcher identifiers and published articles. [2]

Research Profile

The Scopus profile reports 99 documents, 2,808 citations, and an h-index of 27. These figures provide bibliometric indicators of publication activity and citation visibility. Because database metrics change, the latest values should be confirmed directly through the researcher’s Scopus record. [2]

Research Contributions

Her recorded publications examine digital droplet PCR in hematologic malignancies, circulating tumor plasma cells, and antibody-related findings in polycythemia vera. These subjects illustrate the use of molecular methods and clinical investigation to examine complex medical conditions. [3]

Publications

Selected works appear in journals including Diagnostics and the International Journal of Molecular Sciences. Their digital object identifiers provide persistent links to publication records, enabling readers to verify article details and examine the reported research methods and findings. [4]

Research Impact

Citation counts and publication records help describe scholarly visibility but cannot independently establish research quality or clinical effectiveness. A comprehensive assessment also considers methodological rigor, reproducibility, scientific relevance, and how findings contribute to subsequent research. [5]

Award Suitability

The Innovative Research Award profile provides a framework for presenting the researcher’s documented publications and subject expertise. Award eligibility and final selection should be determined by the organizers according to their official criteria, verified supporting documentation, and appropriate evaluation procedures.

Conclusion

Rossella Cacciola’s documented scholarly record reflects research activity in hematology and related medical fields. Her ORCID profile, Scopus record, and DOI-linked publications offer useful resources for examining her academic contributions. Continued verification of bibliographic information supports accurate and transparent research recognition.

References

  1. ORCID. (n.d.). Rossella Rosaria Cacciola: Researcher record.
    https://orcid.org/0000-0003-1440-2695
  2. Elsevier. (n.d.). Scopus author details: Rossella Cacciola, Author ID 7003944169.
    https://www.scopus.com/authid/detail.uri?authorId=7003944169
  3. Galimberti, S., et al. (2022). Digital Droplet PCR in Hematologic Malignancies: A New Useful Molecular Tool. Diagnostics, 12(6), 1305.
    https://doi.org/10.3390/diagnostics12061305
  4. Musso, N., et al. (2022). Label-Free Enrichment of Circulating Tumor Plasma Cells: Future Potential Applications of Dielectrophoresis in Multiple Myeloma. International Journal of Molecular Sciences, 23(19), 12052.
    https://doi.org/10.3390/ijms231912052
  5. Cacciola, R., et al. (2022). Cellular and molecular mechanisms in COVID-19 coagulopathy: role of inflammation and endotheliopathy. Journal of Thrombosis and Thrombolysis.
    https://doi.org/10.1007/s11239-021-02583-4

Liang Liu | Medicine | Best Researcher Award

Published on by Scientific World Research Awards

Best Researcher Award

Researcher Information
Researcher Liang Liu
Affiliation Department of Pancreatic Surgery, Zhongshan Hospital, Fudan University
Country China
Scopus ID 56543839300
Documents 206
Citations 6763
h-index 45
Subject Area Medicine
Event Scientific World Research Awards
ORCID 0000-0002-7826-3877

Liang Liu – Department of Pancreatic Surgery, Zhongshan Hospital, Fudan University

Liang Liu is a medical researcher affiliated with the Department of Pancreatic Surgery at Zhongshan Hospital, Fudan University, China. His scholarly work focuses on pancreatic diseases, gastrointestinal surgery, oncology, clinical medicine, translational research, and surgical innovation. His publication record, citation performance, and sustained research activity indicate substantial academic engagement within the medical sciences. The present article provides a neutral overview of his research profile and summarizes information relevant to academic recognition through the Scientific World Research Awards.[1]

Abstract

Liang Liu has established an active research profile in medicine with emphasis on pancreatic surgery, gastrointestinal oncology, clinical treatment strategies, translational medicine, and evidence-based healthcare. His scholarly publications contribute to improved understanding of pancreatic diseases, surgical management, patient outcomes, and multidisciplinary clinical research. Bibliometric indicators demonstrate sustained scientific productivity and broad academic influence within the international medical research community.[1]

Keywords

  • Pancreatic Surgery
  • Pancreatic Cancer
  • Clinical Oncology
  • Gastrointestinal Surgery
  • Medicine
  • Translational Medicine
  • Clinical Research
  • Cancer Therapy
  • Surgical Oncology
  • Evidence-Based Medicine

Introduction

Medical research plays a fundamental role in advancing healthcare through improved diagnostic methods, innovative therapeutic strategies, and evidence-based clinical practices. Researchers specializing in pancreatic surgery contribute to better understanding of complex diseases and support the development of modern surgical procedures. Liang Liu’s academic activities reflect continued engagement in these areas through clinical investigations, collaborative research, and peer-reviewed scientific publications.[2]

Research Profile

The research profile demonstrates extensive publication activity with 206 indexed documents, more than 6,700 citations, and an h-index of 45 according to Scopus metrics. These indicators reflect sustained scholarly productivity, consistent citation performance, and continued participation in international medical research.[1]

  • Primary discipline: Medicine
  • Clinical and translational medical research
  • Pancreatic disease management
  • Collaborative international publications
  • Evidence-driven clinical investigations

Research Contributions

Liang Liu’s scholarly contributions encompass pancreatic oncology, surgical techniques, perioperative management, clinical outcome evaluation, biomarker research, and multidisciplinary treatment strategies. His publications contribute to the broader scientific understanding of pancreatic disorders while supporting improvements in diagnosis, patient management, and long-term clinical outcomes.[2]

Publications

Research publications include peer-reviewed journal articles addressing pancreatic cancer, gastrointestinal diseases, translational medicine, clinical surgery, precision treatment approaches, and multidisciplinary healthcare. These studies collectively contribute to contemporary medical literature and are indexed within major scientific databases.[3]

  • Clinical oncology studies
  • Pancreatic surgery research
  • Multidisciplinary treatment evaluation
  • Evidence-based clinical investigations

Research Impact

Citation metrics and publication performance indicate that Liang Liu’s work has been referenced by researchers involved in surgery, oncology, gastroenterology, and translational medicine. Such bibliometric indicators suggest continuing academic visibility and engagement within the medical research community while supporting ongoing scientific collaboration.[1]

Award Suitability

Based on publicly available bibliometric indicators, publication activity, citation performance, and contributions to medical science, Liang Liu demonstrates characteristics commonly considered during evaluation for academic recognition programs. Eligibility and final selection for the Scientific World Research Awards remain subject to the official assessment criteria established by the award organizers.[4]

Conclusion

Liang Liu maintains an established research profile within medicine through scholarly publications, citation impact, and clinical research contributions. His work supports continued advancement in pancreatic surgery and related medical disciplines while reflecting sustained participation in evidence-based scientific research.[1]

References

  1. Histone deacetylases: A novel class of therapeutic targets for pancreatic cancer
    https://www.sciencedirect.com/science/article/abs/pii/S0304419X22000014
  2. Patterns and predictors of pancreatic neuroendocrine tumor prognosis: Are no two leaves alike?
    https://www.researchgate.net/publication/355240016_Patterns_and_predictors_of_pancreatic_neuroendocrine_tumor_prognosis_Are_no_two_leaves_alike
  3. Sequential Capecitabine/Temozolomide and Sunitinib Treatment in Patients With Metastatic Well-Differentiated Grade 1/Grade 2 Pancreatic Neuroendocrine Tumors
    https://www.sciencedirect.com/science/article/abs/pii/S1530891X21011794
  4. Scientific World Research Awards.
    https://scientificworld.net/

Miglena Marinova Achkar | Medicine | Innovative Research Award

Published on by Scientific World Research Awards

Innovative Research Award

Researcher Information
Affiliation Medical University Varna
Country Bulgaria
Scopus ID 57739433300
Documents 3
Citations 33
h-index 2
Subject Area Medicine
Event Scientific World Research Awards

Miglena Marinova Achkar

Medical University Varna, Bulgaria

Miglena Marinova Achkar is affiliated with Medical University Varna, Bulgaria, and has contributed to medical research focusing on pediatric allergy, environmental determinants of disease, and preventive healthcare. Her scholarly publications demonstrate an evidence-based approach to clinical medicine and public health, making her profile relevant for recognition through the Scientific World Research Awards.[1]

Abstract

This article summarizes the academic profile of Miglena Marinova Achkar, highlighting scholarly activities in medicine, pediatric allergy, and environmental health research. Available publication metrics and research outputs indicate contributions supporting evidence-based healthcare and preventive medicine while demonstrating suitability for academic recognition.[1]

Keywords

Medicine, Pediatrics, Allergy, Environmental Health, Atopy, Child Health, Epidemiology, Preventive Medicine, Clinical Research, Bulgaria

Introduction

Miglena Marinova Achkar’s research focuses on pediatric medicine and allergic diseases, emphasizing environmental influences on childhood health. Her published studies contribute valuable clinical observations supporting preventive healthcare strategies and encourage evidence-based decision-making for physicians, researchers, and healthcare policymakers.[1]

Research Profile

Her Scopus profile includes peer-reviewed publications addressing pediatric allergy and environmental determinants affecting children’s health. With measurable citations and an established h-index, her academic record reflects participation in internationally indexed research contributing to contemporary medical knowledge.[1]

Research Contributions

Her investigations examine relationships between environmental exposures and allergic conditions among children with hereditary susceptibility. These findings provide clinically relevant evidence supporting early prevention, risk assessment, and improved understanding of pediatric allergic disease development within healthcare practice.[1]

Publications

Published research includes studies investigating environmental determinants of allergic diseases in children, emphasizing epidemiological evaluation and clinical interpretation. These peer-reviewed publications contribute reliable scientific evidence supporting pediatric medicine, allergy prevention, and public health research initiatives.[1]

Research Impact

Citation metrics indicate that her work has attracted scholarly attention within pediatric and allergy research communities. The research supports ongoing investigations into childhood allergic diseases and contributes useful evidence for improving preventive healthcare and clinical management practices.[1]

Award Suitability

Her documented research achievements, peer-reviewed publications, citation record, and commitment to pediatric medical science demonstrate qualities aligned with the objectives of the Scientific World Research Awards. The profile reflects meaningful academic contributions deserving consideration for research recognition.[1]

Conclusion

Miglena Marinova Achkar has established an emerging academic profile through research addressing pediatric allergy and environmental health. Her publications, citations, and evidence-based investigations contribute to medical science while supporting continued scholarly development and international academic recognition.[1]

 

References

  1. Early-Life Environmental Determinants of Allergic Conditions in Children with Atopic Heredity: A Single Center Cross-Sectional Study from Bulgaria.
    https://www.mdpi.com/2076-3271/13/3/198
  2. Elsevier. (n.d.). Scopus author details: Miglena Marinova Achkar, Author ID 57739433300. Scopus.

    https://www.scopus.com/authid/detail.uri?authorId=57739433300
  3. Scientific World Research Awards. (n.d.). Scientific World Research Awards.
    https://scientificworld.net/

Hamid Safarzadeh | Medicine | Best Researcher Award

Published on by Scientific World Research Awards

Best Researcher Award

Hamid Safarzadeh
Affiliation University of Palermo
Country Italy
Scopus ID 57811418200
Documents 24
Citations 38
h-index 3
Subject Area Medicine
Event Scientific World Research Awards
ORCID 0000-0001-5108-2104

Hamid Safarzadeh is a distinguished clinical scholar affiliated with the University of Palermo in Italy. His scholarly investigations operate within the broader domain of clinical medicine, placing particular emphasis on specialized imaging assessment methodologies, patient diagnostics, and procedural optimization paradigms. Through consistent empirical inquiry and academic rigor, his output addresses critical gaps in therapeutic monitoring and interventional safety protocols. His standard of research excellence has positioned him as a candidate for the Best Researcher Award presented by the Scientific World Research Awards.

1. Abstract

This academic overview examines the clinical contributions and scholarly milestones achieved by Hamid Safarzadeh within modern medicine. Through systematic quantitative evaluations and peer-reviewed outputs, Safarzadeh has significantly refined diagnostic evaluation methodologies and clinical protocols. His active clinical research infrastructure at the University of Palermo focuses on mitigating procedural risk indices, enhancing standard imaging efficacy, and formalizing evidence-based diagnostic metrics. By evaluating his bibliometric indicators—including a curated database of 24 scholarly documents, critical citation records, and clinical trial oversight architectures—this page illustrates his scientific path, collaborative networks, and suitability for the Best Researcher Award.

2. Keywords

Clinical Medicine; Medical Imaging Diagnostics; Evidence-Based Healthcare; Procedural Optimization; Academic Metrics; Risk Mitigation Protocols.

3. Introduction

Modern medical research depends heavily on systematic clinical validation frameworks to transition laboratory concepts into practical diagnostic environments [1]. Hamid Safarzadeh’s ongoing medical research addresses this need by focusing directly on clinical standardization and improving diagnostics within institutional systems.

4. Research Profile

Based at the University of Palermo, Safarzadeh’s profile includes 24 peer-reviewed manuscripts indexed globally. His academic focus spans clinical workflows, radiological safety, and evidence-based tracking, establishing structured assessment loops within institutional settings [2].

5. Research Contributions

Safarzadeh’s key scientific inputs focus on establishing technical baselines to decrease adverse post-procedural events. His collaborative models integrate cross-disciplinary diagnostics to solve complex problems in modern clinical pathology and patient safety management.

6. Publications

His published material spans recognized, peer-reviewed international medical journals. These publications explore clinical precision frameworks, advanced imaging, and systemic analytical tools designed to monitor patient outcomes accurately over extended periods [3].

7. Research Impact

With an h-index of 3 and 38 independent citations, his published literature displays steady institutional pickup. These tracking metrics reflect growing professional engagement with his diagnostic methodologies and clinical safety evaluations [4].

8. Award Suitability

Safarzadeh’s rigorous academic alignment, structured dataset creations, and distinct focus on medical practice safety align directly with the criteria for the Best Researcher Award, showing a dedication to clear clinical research.

9. Conclusion

In summary, Hamid Safarzadeh’s systematic work at the University of Palermo enhances precision within clinical medical tracking. His peer-reviewed publication footprint points toward sustained advancements in diagnostic evaluation frameworks worldwide [5].

11. References

  1. Elsevier. (n.d.). Scopus author details: Hamid Safarzadeh, Author ID 57811418200. Scopus.

    https://www.scopus.com/authid/detail.uri?authorId=57811418200

  2. Pugliesi, R. A., Muna, S. F., Mahnken, A. H., Maalouf, N., Chatzis, G., & Apitzsch, J. (2026). Exploratory Analysis of Early Renal Function Changes After Transcatheter Aortic Valve Implantation (TAVI). Journal of Clinical Medicine, 15(10), 3726.

    https://doi.org/10.3390/jcm15103726

  3. Pugliesi, R. A., Maalouf, N., Gullo, G., Mahnken, A. H., & Apitzsch, J. (2026). Pulmonary Hemorrhage and Pneumothorax Risk During CT-Guided Lung Biopsy for Suspected Lung Cancer. Cancers, 18(5), 0743.

    https://doi.org/10.3390/cancers18050743

  4. Pugliesi, R. A., Ben Mansour, K., Apitzsch, J., Papachristodoulou, A., Rafailidis, V., & Katz, D. S. (2025). Meta-Analysis of AI Integration in Abdominal Imaging for Liver Fibrosis and MASLD. Journal of Clinical Medicine, 14(23), 8466.

    https://doi.org/10.3390/jcm14238466

  5. Pugliesi, R. A., Nasser, Y., Benchekroun, A., BenAyed, R., Mahnken, A. H., Maalouf, N., & Apitzsch, J. (2025). Impact of Technical Standardization on Pneumothorax and Chest Tube Insertion Rates. Journal of Clinical Medicine, 14(14), 4838.

    https://doi.org/10.3390/jcm14144838

Anuradha Kunthur | Medicine | Innovative Research Award

Published on by Scientific World Research Awards

Innovative Research Award

Anuradha Kunthur
University of Arkansas

Anuradha Kunthur
Affiliation University of Arkansas
Country United States
Scopus ID 12805295200
Documents 7
Citations 154
h-index 5
Subject Area Medicine
Event Scientific World Research Awards

The Innovative Research Award recognizes scholarly achievement, research originality, and meaningful contributions to scientific advancement. This academic recognition article highlights the research profile, publication record, and scholarly influence of Anuradha Kunthur, affiliated with the University of Arkansas. The assessment considers research productivity, citation performance, subject expertise, and potential contributions to the advancement of medical sciences. The profile reflects academic indicators commonly used in research evaluation and award selection processes.[1]

Abstract

This article presents an academic overview of Anuradha Kunthur and evaluates the researcher’s suitability for the Innovative Research Award. Affiliated with the University of Arkansas, the researcher has contributed to the field of medicine through scholarly publications, interdisciplinary inquiry, and evidence-based investigations. Academic performance indicators, including publication output, citation activity, and h-index values, demonstrate measurable engagement with the scientific community. The profile highlights research accomplishments, publication quality, scholarly influence, and broader relevance to contemporary medical challenges. These characteristics collectively support recognition within competitive international research award programs and academic excellence initiatives.[1][2]

Keywords

Innovative Research Award, Medical Research, Scholarly Impact, Citation Analysis, Research Excellence, University of Arkansas, Scientific Achievement, Academic Recognition.

Introduction

Academic awards play an important role in recognizing research excellence, innovation, and scientific contributions. The Innovative Research Award acknowledges researchers whose scholarly activities demonstrate originality, methodological rigor, and relevance to advancing knowledge. Evaluation often includes publication quality, citation influence, and contributions to addressing real-world challenges through scientific investigation.[2]

Research Profile

Anuradha Kunthur is affiliated with the University of Arkansas and has established a research profile within the medical sciences. The available scholarly metrics indicate a focused publication record supported by consistent citation activity. Research visibility reflected through indexed publications and citation performance demonstrates engagement with international academic audiences and contribution to evidence-based scientific discourse.[1]

Research Contributions

The researcher’s contributions are associated with advancing understanding in medicine through analytical investigation and scholarly publication. Research activities support the development of scientific knowledge, encourage interdisciplinary collaboration, and provide insights relevant to healthcare improvement. Citation performance suggests that published findings have contributed to ongoing academic discussions and informed subsequent studies within related fields.[1][3]

Publications

The publication portfolio consists of peer-reviewed scholarly works indexed within recognized academic databases. These publications contribute to the dissemination of research findings and support broader scientific communication. The documented publication count, combined with citation activity, reflects sustained participation in scholarly publishing and knowledge exchange within the medical research community.[1]

Research Impact

Research impact can be assessed through citation metrics, scholarly visibility, and influence on future investigations. With 154 citations and an h-index of 5, the researcher demonstrates measurable academic engagement. These indicators suggest that published work has attracted attention from peers and contributed to the broader scientific literature in meaningful ways.[1][4]

Award Suitability

The Innovative Research Award emphasizes originality, scientific contribution, and measurable research influence. Based on available academic indicators, Anuradha Kunthur demonstrates characteristics aligned with award evaluation criteria. Publication output, citation performance, institutional affiliation, and documented scholarly activity collectively support consideration for recognition within international research award programs dedicated to scientific excellence and innovation.[1][2]

Conclusion

Anuradha Kunthur’s academic profile reflects meaningful participation in medical research through scholarly publication and citation impact. The combination of research productivity, scientific engagement, and measurable scholarly influence supports recognition within the framework of the Innovative Research Award. Continued research activity and knowledge dissemination are expected to contribute positively to the advancement of medical science and academic scholarship.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Anuradha Kunthur, Author ID 12805295200. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=12805295200
  2. Scientific World Research Awards. (n.d.). Innovative Research Award evaluation and recognition framework.
    https://scientificworld.net/
  3. Marisa Navoa ∙ Anuradha Kunthurb ∙ Martina L. Badell. (2006). Evaluation of the incidence of carboplatin hypersensitivity reactions in cancer patients.
    https://doi.org/10.1016/j.ygyno.2006.04.002
  4. Anuradha Kunthur. (2019). A castrate-resistant metastatic prostate cancer patient with severe pancytopenia, successfully treated with docetaxel chemotherapy.
    https://doi.org/10.1177/1078155219890653

Sihe Zhang | Medicine | Distinguished Scientist Award

Published on by Scientific World Research Awards

Distinguished Scientist Award

Sihe Zhang
Nankai University, China

Sihe Zhang
Affiliation Nankai University
Country China
Scopus ID 7409373738
Documents 55
Citations 1,269
h-index 16
Subject Area Medicine
Event Scientific World Research Awards
ORCID 0000-0002-8923-1993

The Distinguished Scientist Award recognizes the scholarly achievements of Sihe Zhang, Professor and Director at Nankai University School of Medicine. His research focuses on cancer biology, drug delivery systems, endocytosis, extracellular vesicles, antibody therapeutics, and translational medicine. Through sustained contributions to hepatocellular carcinoma and ovarian cancer research, he has developed innovative approaches that connect molecular mechanisms with therapeutic applications.[1]

Abstract

Sihe Zhang is a biomedical researcher whose work spans cancer biology, antibody engineering, cellular uptake mechanisms, extracellular vesicle biology, and targeted therapeutic delivery. His investigations have contributed to understanding macropinocytosis, endocytic recycling, tumor progression, and resistance mechanisms in hepatocellular and ovarian cancers. He has also participated in the development of innovative antibody-based therapies and nanomedicine strategies aimed at improving treatment specificity and efficacy. His publication portfolio demonstrates a sustained commitment to translational medical research and interdisciplinary collaboration, supporting advancements in cancer diagnosis, drug delivery, and precision medicine.[1][2]

Keywords

Cancer Biology; Drug Delivery; Endocytosis; Extracellular Vesicles; Antibody Therapeutics; Hepatocellular Carcinoma; Ovarian Cancer; Nanomedicine.

Introduction

Professor Zhang has held academic positions at Nankai University and previously at the Fourth Military Medical University. His career reflects long-term engagement with molecular medicine and cell biology, emphasizing mechanisms that influence cancer progression and treatment response.[1]

Research Profile

His research profile combines laboratory discovery with translational applications. Major themes include cellular trafficking, therapeutic antibodies, tumor microenvironment studies, and targeted delivery platforms designed to improve treatment outcomes in oncology.[1]

Research Contributions

Notable contributions include investigations into CD147-mediated signaling, extracellular vesicle uptake, macropinocytosis-driven drug resistance, and antibody-based cancer therapies. These studies have expanded understanding of tumor biology and therapeutic targeting strategies.[2][3]

Publications

His scholarly record includes 55 indexed publications. Representative works address hepatocellular carcinoma resistance mechanisms, extracellular vesicle biology, peptide delivery systems, anti-CD147 therapeutics, and nanobiotechnology-based treatment approaches.[2][4]

Research Impact

With 1,269 citations and an h-index of 16, his research has influenced studies in cancer therapeutics, molecular oncology, and biomedical engineering. The impact of his work is reflected through citations, collaborations, and peer-review activities across leading journals.[1]

Award Suitability

The breadth of Professor Zhang’s contributions, combined with sustained publication output and translational relevance, aligns with the objectives of the Scientific World Research Awards. His work demonstrates scientific rigor and practical relevance in medicine.[1]

Conclusion

Sihe Zhang has established a recognized research portfolio in cancer biology and therapeutic innovation. His scholarly achievements and ongoing contributions support recognition through the Distinguished Scientist Award.[1]

References

  1. ORCID. (2026). Sihe Zhang (0000-0002-8923-1993) Research Profile.https://orcid.org/0000-0002-8923-1993
  2. Qian, L., et al. (2025). The uptake of extracellular vesicles: Research progress in cancer drug resistance and beyond. Drug Resistance Updates.https://doi.org/10.1016/j.drup.2025.101209
  3. Qi, F.Z., et al. (2024). Hypoxia-activated ADCC-enhanced humanized anti-CD147 antibody. MedComm.https://doi.org/10.1002/mco2.512
  4. Sun, Z., et al. (2023). Cell-Penetrating Peptide-Based Delivery of Macromolecular Drugs. Biomedicines.https://doi.org/10.3390/biomedicines11071971
  5. Wang, B., et al. (2024). Hypoxia-activated selectivity-improved anti-PKM2 antibody combined with prodrug TH-302. International Journal of Biological Sciences.https://doi.org/10.7150/ijbs.92211

Asterios Deligiannis | Medicine | Best Innovation Award

Published on by Scientific World Research Awards

Best Innovation Award

Asterios Deligiannis

Researcher Information
Affiliation Aristotle University of Thessaloniki
Country Greece
Scopus ID 7003501457
Documents 127
Citations 5,944
h-index 28
Subject Area Chemistry
Event Scientific World Research Awards
ORCID 0000-0001-7765-1897

Asterios Deligiannis is an academic affiliated with Aristotle University of Thessaloniki, Greece. His scholarly record demonstrates extensive research productivity, interdisciplinary collaboration, and sustained scientific contribution. According to available research metrics, he has produced 127 indexed publications, received 5,944 citations, and achieved an h-index of 28, reflecting broad academic visibility and influence across multiple research domains.[1][2]

Abstract

This article presents an overview of the academic achievements of Asterios Deligiannis. His research portfolio encompasses a substantial body of scholarly work, international collaborations, and contributions to scientific knowledge. Available publication metrics indicate 127 indexed documents, 5,944 citations, and an h-index of 28, reflecting sustained research productivity and scholarly influence.[1] His academic activities include participation in international research initiatives, professional organizations, and peer-reviewed publications. These accomplishments demonstrate innovation, research leadership, and measurable scientific impact, supporting consideration for recognition through the Best Innovation Award within an international academic framework.[2]

Keywords

Innovation, Chemistry, Scientific Research, Academic Impact, Research Excellence, Scholarly Contributions.

Introduction

Research innovation is commonly assessed through scientific productivity, influence, and contributions to knowledge development. Academic recognition programs frequently consider publication records, citation performance, and interdisciplinary engagement when evaluating researchers for distinguished awards.[1]

Research Profile

Deligiannis is affiliated with Aristotle University of Thessaloniki and maintains an active ORCID record. His professional activities include academic leadership, international memberships, and participation in collaborative research programs.[2]

Research Contributions

His scholarly contributions span cardiovascular health, exercise-related investigations, rehabilitation studies, and interdisciplinary scientific research. Numerous peer-reviewed publications demonstrate long-term engagement in advancing evidence-based knowledge and innovation.[3]

Publications

The researcher has authored 127 indexed publications and contributed to a broad collection of scientific articles published in international journals. His publication record reflects sustained scholarly activity and extensive collaboration across research communities.[1]

Research Impact

Research influence is demonstrated through 5,944 citations and an h-index of 28. These indicators suggest significant academic visibility and continuing relevance of his publications within scientific literature and research networks.[1]

Award Suitability

The combination of research productivity, scholarly impact, international engagement, and documented scientific contributions supports consideration for the Best Innovation Award. His profile reflects characteristics commonly associated with academic distinction and innovation-oriented recognition.[1]

Conclusion

Asterios Deligiannis has established a substantial academic record characterized by impactful publications, collaborative research activities, and measurable scholarly influence. These achievements provide a strong foundation for recognition within international research award programs.

References

  1. Elsevier. (n.d.). Scopus Author Details: Asterios Deligiannis, Author ID 7003501457. Scopus.

    https://www.scopus.com/authid/detail.uri?authorId=7003501457

  2. ORCID. (2026). Asterios Deligiannis ORCID Record.

    https://orcid.org/0000-0001-7765-1897

  3. Deligiannis, A., et al. (2025). Investigating the Role of Exercise in Improving Bone Health Among Elderly Women with Osteopenia.

    https://doi.org/10.3390/jfmk10040451

  4. Deligiannis, A., et al. (2025). Advanced Stress Echocardiography with Cardiopulmonary Exercise Testing After Myocardial Infarction.

    https://doi.org/10.3390/jfmk10040393

  5. Scientific World Research Awards. (n.d.). Official Award Information Portal.

    https://scientificworld.net/

Charles Dariane | Medicine | Research Excellence Award

Published on by Scientific World Research Awards

Assist. Prof. Dr. Charles Dariane | Medicine | Research Excellence Award

MD PhD | European Hospital Georges Pompidou | France

Assist. Prof. Dr. Charles Dariane is a leading researcher in urologic oncology, focusing on prostate and renal cancer, advanced imaging, and robotic-assisted surgery. His research skills include clinical trials, surgical innovation, and multidisciplinary collaboration. He has contributed to international cancer guidelines and impactful publications. His Scopus metrics include 1,429 citations, 155 documents, and an h-index of 19. His work enhances precision medicine and improves outcomes in modern urological cancer care.

 

Citation Metrics (Scopus)

1429
1000
700
300
0

Citations

1429

Documents

155

h-index

19

Citations

Documents

h-index

View Scopus Profile

Featured Publications

 

Jacek Kotuła | Medicine | Research Excellence Award

Published on by Scientific World Research Awards

Assist. Prof. Dr. Jacek Kotuła | Medicine | Research Excellence Award

Doctor | University of Wrocław | Poland

Assist. Prof. Dr. Jacek Kotuła, affiliated with Wrocław Medical University, is a researcher in orthodontics, dentistry, and medical ethics. His research interests include cephalometric analysis, bone remodeling, and orthodontic biomechanics. He has strong skills in CBCT imaging, finite element modeling, and clinical research. With impactful publications in medical journals, he has gained academic recognition. According to Google Scholar, he has 230 citations, an h-index of 9, and an i10-index of 8, reflecting his contributions to modern orthodontic science.

 

Citation Metrics (Google Scholar)

230
150
100
50
0

Citations

230

i10-index

8

h-index

9

Citations

i10-index

h-index

View Google Scholar Profile

Featured Publications